560 related articles for article (PubMed ID: 34403771)
1. Advances in clinical immunotherapy for gastric cancer.
Li K; Zhang A; Li X; Zhang H; Zhao L
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188615. PubMed ID: 34403771
[TBL] [Abstract][Full Text] [Related]
2. Progress and prospects of immune checkpoint inhibitors in advanced gastric cancer.
Zeng Z; Yang B; Liao Z
Future Oncol; 2021 Apr; 17(12):1553-1569. PubMed ID: 33397136
[TBL] [Abstract][Full Text] [Related]
3. Application of immune checkpoint inhibitors in immunotherapy for gastric cancer.
Wu YX; Zhou XY; Wang JQ; Chen GM; Chen JX; Wang RC; Huang JQ; Chen JS
Immunotherapy; 2023 Feb; 15(2):101-115. PubMed ID: 36597704
[TBL] [Abstract][Full Text] [Related]
4. [Advances in predictive biomarkers associated with immune checkpoint inhibitors for tumor therapy].
Guo R; Li X; Hao M; Liang Y; Wang L; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1403-1424. PubMed ID: 37154314
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitors and cellular immunotherapy for advanced gastric, gastroesophageal cancer: a long pathway.
Cheng R; Li B; Wang H; Zeng Y
Clin Transl Oncol; 2023 Nov; 25(11):3122-3138. PubMed ID: 37036597
[TBL] [Abstract][Full Text] [Related]
6. Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer.
Han Z; Zhang Z; Yang X; Li Z; Sang S; Islam MT; Guo AA; Li Z; Wang X; Wang J; Zhang T; Sun Z; Yu L; Wang W; Xiong W; Li G; Jiang Y
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38749538
[TBL] [Abstract][Full Text] [Related]
7. Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers.
Davern M; Lysaght J
Cancer Lett; 2020 Dec; 495():89-99. PubMed ID: 32950619
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of immunotherapy in biliary tract cancer: a review of new evidence and predictive biomarkers.
Giorgione R; Risaliti M; Bartolini I; Rossi G; Pillozzi S; Muiesan P; Taddei A; Antonuzzo L
Immunotherapy; 2022 May; 14(7):567-576. PubMed ID: 35382560
[TBL] [Abstract][Full Text] [Related]
9. Role of Immunotherapy in Triple-Negative Breast Cancer.
Keenan TE; Tolaney SM
J Natl Compr Canc Netw; 2020 Apr; 18(4):479-489. PubMed ID: 32259782
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of gastric cancer: Past, future perspective and challenges.
Xie J; Fu L; Jin L
Pathol Res Pract; 2021 Feb; 218():153322. PubMed ID: 33422778
[TBL] [Abstract][Full Text] [Related]
11. Current status of immune checkpoint inhibitors for gastric cancer.
Kono K; Nakajima S; Mimura K
Gastric Cancer; 2020 Jul; 23(4):565-578. PubMed ID: 32468420
[TBL] [Abstract][Full Text] [Related]
12. Current status of immunotherapy for advanced gastric cancer.
Kawazoe A; Shitara K; Boku N; Yoshikawa T; Terashima M
Jpn J Clin Oncol; 2021 Jan; 51(1):20-27. PubMed ID: 33241322
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer.
Lazăr DC; Avram MF; Romoșan I; Cornianu M; Tăban S; Goldiș A
World J Gastroenterol; 2018 Aug; 24(32):3583-3616. PubMed ID: 30166856
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of immune checkpoint inhibitors in neoadjuvant therapy for gastric cancer].
Zhu ZG
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1331-1336. PubMed ID: 38644278
[TBL] [Abstract][Full Text] [Related]
15. T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs).
Rallis KS; Hillyar CRT; Sideris M; Davies JK
Anticancer Res; 2021 Mar; 41(3):1123-1141. PubMed ID: 33788704
[TBL] [Abstract][Full Text] [Related]
16. The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity.
Ge Y; Wei F; Du G; Fei G; Li W; Li X; Chu J; Wei P
BMC Cancer; 2021 Mar; 21(1):240. PubMed ID: 33678158
[TBL] [Abstract][Full Text] [Related]
17. Adenosine signaling: Optimal target for gastric cancer immunotherapy.
Wang J; Du L; Chen X
Front Immunol; 2022; 13():1027838. PubMed ID: 36189223
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in immune therapies for gastric cancer.
Olnes MJ; Martinson HA
Cancer Gene Ther; 2021 Sep; 28(9):924-934. PubMed ID: 33664460
[TBL] [Abstract][Full Text] [Related]
19. Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma.
Hotta K; Fujimoto N
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32098830
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutic advances in gastric cancer.
Yoneda A; Kuroki T; Eguchi S
Surg Today; 2021 Nov; 51(11):1727-1735. PubMed ID: 33590326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]